Challenging the superiority of amiodarone for rate control in Wolff-Parkinson-White and atrial fibrillation

被引：0
|
作者：
Sharis M. Simonian
Shahram Lotfipour
Christopher Wall
Mark I. Langdorf
机构：
[1] University of California,Department of Emergency Medicine
[2] Irvine School of Medicine,Emergency Ultrasound
[3] University of California,undefined
[4] Irvine School of Medicine,undefined
[5] Hennepin County Medical Center,undefined
来源：
Internal and Emergency Medicine | 2010年 / 5卷
关键词：
Amiodarone; Procainamide; Wolff-Parkinson-White (WPW); Atrial fibrillation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The objective of this review is to explore and challenge the superiority of amiodarone for rate control in Wolff-Parkinson-White syndrome and concomitant atrial fibrillation (WPW-AF). The current recommendation for pharmacological treatment of this condition is amiodarone. A review of the past 25 years of literature finds several studies that identify a small risk of ventricular fibrillation secondary to amiodarone administration for rate control in WPW-AF. Additionally, the literature supports the safe and effective use of procainamide for rate control in WPW-AF. This review concludes that amiodarone is not superior to procainamide in rate control for WPW-AF, and may be dangerous.
引用
收藏
页码：421 / 426
页数：5
相关论文
共 50 条
  • [41] AMIODARONE IN CONTROL OF SUSTAINED TACHYARRHYTHMIAS IN CHILDREN WITH THE WOLFF-PARKINSON-WHITE SYNDROME
    SHAHAR, E
    FEIGEL, A
    BARZILAY, Z
    FRAND, M
    [J]. ISRAEL JOURNAL OF MEDICAL SCIENCES, 1982, 18 (10): : 1070 - 1070
  • [42] STUDY OF OCCURING MECHANISM OF ATRIAL FIBRILLATION IN WOLFF-PARKINSON-WHITE SYNDROME
    Meng Fanchao Huang Yonglin Zhou Xiurong. The First Chinical Medical College of Harbin Medical University
    [J]. 中国介入心脏病学杂志, 1998, (04) : 192 - 192
  • [43] Atrial fibrillation and Wolff-Parkinson-White syndrome: A double blow for the cardiologist
    Bazoukis, George
    Papasavvas, Elias
    Pavlou, Marios
    Georgiou, Panagiota
    Kapetis, Lorentzos
    Patestos, Dimitrios
    Vlachos, Konstantinos
    Saplaouras, Athanasios
    Letsas, Konstantinos P.
    Efremidis, Michael
    Tsielepis, Michalis
    [J]. CLINICAL CASE REPORTS, 2022, 10 (07):
  • [44] Clinical presentation and treatment of atrial fibrillation in Wolff-Parkinson-White syndrome
    Thanavaro, Joanne L.
    Thanavaro, Samer
    [J]. HEART & LUNG, 2010, 39 (02): : 131 - 136
  • [45] EFFECT OF FLESTOLOL ON VENTRICULAR RATE DURING ATRIAL-FIBRILLATION IN WOLFF-PARKINSON-WHITE SYNDROME
    SWERDLOW, CD
    PETERSON, J
    LIEM, LB
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1988, 62 (01): : 78 - 82
  • [46] DISOPYRAMIDE IN PATIENTS WITH WOLFF-PARKINSON-WHITE SYNDROME AND ATRIAL-FIBRILLATION
    BENNETT, DH
    [J]. CHEST, 1978, 74 (06) : 624 - 628
  • [47] The correlated factors of Wolff-Parkinson-White syndrome complicated with atrial fibrillation
    Luo, Qiang
    Chen, Liang
    Yang, Donghui
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (16) : C114 - C114
  • [48] WOLFF-PARKINSON-WHITE SYNDROME AND ATRIAL-FIBRILLATION - PATHOGENESIS AND THERAPY
    DUCKECK, W
    KUCK, KH
    [J]. HERZ, 1993, 18 (01) : 60 - 66
  • [49] WOLFF-PARKINSON-WHITE SYNDROME - ATRIAL-FIBRILLATION AS THE PRESENTING ARRHYTHMIA
    ROBINSON, K
    ROWLAND, E
    KRIKLER, DM
    [J]. BRITISH HEART JOURNAL, 1988, 59 (05): : 578 - 580
  • [50] MEDICAL THERAPY IN THE WOLFF-PARKINSON-WHITE SYNDROME AND ATRIAL-FIBRILLATION
    SLEDGE, C
    SCHEINMAN, M
    MORADY, F
    SHEN, E
    SHAPIRO, W
    SUNG, R
    [J]. CIRCULATION, 1982, 66 (04) : 269 - 269
12345